Tolazoline hydrochloride
 OpenBabel02212023462D

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.7889    0.2237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7889   -0.6013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4563   -1.0863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2014   -1.8709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3764   -1.8709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1214   -1.0863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5033    0.6362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5033    1.4612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2178    1.8737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9323    1.4612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9323    0.6362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2178    0.2237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0  0  0  0
  2  8  1  0  0  0  0
  3  4  2  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  2  0  0  0  0
  8 13  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
M  END
>  <CdId>
970

>  <Mol Weight>
196.677

>  <Formula>
C10H13ClN2

>  <ID>
T1680

>  <Name>
Tolazoline hydrochloride

>  <Synonyms>
Imidaline hydrochloride;Benzidazol hydrochloride

>  <CAS>
59-97-2

>  <Approved status>
FDA

>  <Disease>
Cardiovascular system

>  <Indication>
Spasms Of Peripheral Blood Vessels; Peripheral Vasoconstriction

>  <Pathways>
GPCR/G Protein

>  <Target>
Adrenergic Receptor antagonist

>  <Receptor>
¦Á-adrenergic receptor

$$$$
